$55.00
In stock
The CJC-1295 no DAC/ipamorelin blend is a synergistic research peptide combination that potently amplifies physiological pulsatile GH secretion of growth hormone via dual GHRH-receptor and ghrelin-receptor agonism. Research applications are enhanced fat loss, muscle anabolism, recovery, and sleep benefits while minimizing off-target hormone elevation,
Store in a cool, dark place or freeze at -20°C for long term storage. Refrigerate after reconstitution
CJC1295 (no DAC): 5MG
Ipamorelin: 5MG
CJC-1295 without DAC combined with Ipamorelin is a research peptide blend designed to synergistically stimulate pulsatile growth hormone (GH) release while preserving the natural physiological rhythm of the somatotropic axis. CJC-1295 no DAC ([D-Ala², Gln⁸, Ala¹⁵, Leu²⁷]-GRF(1–29)-NH₂; CAS 863288-34-0) is a 29-amino-acid modified analog of growth hormone-releasing hormone (GHRH) with four strategic substitutions that confer resistance to plasma dipeptidyl peptidase-IV degradation, yielding a short half-life of ~6–8 minutes but markedly increased intrinsic activity compared to native GHRH. Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH₂; CAS 170851-70-4), a selective pentapeptide ghrelin mimetic and growth hormone secretagogue (GHS), potently stimulates GH release via the ghrelin receptor (GHS-R1a) on somatotrophs with minimal elevation of cortisol, prolactin, or ACTH — Preclinical data suggests the blend promotes fat loss, lean body mass accrual, improves recovery from injury, enhances sleep quality (particularly deep-stage sleep), supports collagen synthesis and joint health, and exerts mild anti-inflammatory and cardioprotective effects through elevated IGF-1 signaling.
All items available on this website are intended exclusively for research and development purposes, including laboratory and analytical applications, and are not meant for human or animal consumption in any form. The products are not designed to diagnose, treat, cure, or prevent any medical conditions, and their associated claims have not been reviewed or approved by the U.S. Food and Drug Administration. Purus Peptides operates solely as a supplier of research chemicals and is neither a compounding pharmacy nor an outsourcing facility as defined by sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act
All products are sold in powder (lyophilized) form and require reconstitution with a suitable dilutant for research purposes only. Research supplies (e.g., syringes, bacteriostatic water) are not included. No dosing instructions are provided. We adhere to all local and state laws around Research Only Chemical sales. We are not a pharmacy, nor do we promote or provide any advice for human or animal consumption. Please review our terms and conditions carefully before making a purchase on our website.
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above.
